INSTRUCTION FOR AUTHORS
Journal of Cancer Reahabilitation is a international peer-reviewed, quately journal dedicated to disseminating cuttingedge data and clinically relevant information to the practicing clinician and healthcare professional.
Each manuscript includes:
• Forename(s) and surnames of authors (see Authorship section below)
• Author affiliations: department, institution, city, state, country
• Abstract 300 words
• 3–6 keywords
• Running header (shortened title)
• Corresponding author: name, physical address, phone, fax, email
• Reference list
• 3-cm margins
• Page numbers
• Clear concise language
• American spelling
• Ensure tables and figures are cited
• The preferred electronic format for text is Microsoft Word
• Manuscripts will be accepted in LaTeX as long as the native LaTeX and a PDF is also supplied
• Use International Systems of Units (SI) symbols and recognized abbreviations for units of measurement
• Do not punctuate abbreviations eg, et al, ie
• Spell out acronyms in the first instance in the abstract and paper
• Word counts are not specified. In general, shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500
• Generic drug names are used in text, tables, and figures
• Suppliers of drugs, equipment, and other brand-name material are credited in parentheses (company, name, city, state, country)
• If molecular sequences are used, provide a statement that the data have been deposited in a publicly accessible database, eg, GenBank, and indicate the database accession number. While the editors fully understand the extra challenges posed to authors whose native language is not English, we must ask that all manuscripts be reviewed and edited by a native speaker of English with expertise in that area prior to submission.
Authorship credit should be based on:
1) Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
2) Drafting the article or revising it critically for important intellectual content;
3) Final approval of the version to be published; and
4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript (3). These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. The NLM indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship/contributorship. The group should jointly make decisions about contributors/authors before submitting the manuscript for publication. The corresponding author/guarantor should be prepared to explain the presence and order of these individuals. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship.
Where authors of a paper are related this should be disclosed at the time of submission. Please provide details of the family relationship between such authors.
Figures and Tables
• Submit as separate files and also as one combined file
• Submit figures as JPG files
• Number consecutively
• Provide a descriptive heading/legend
• Place abbreviations immediately below the table
• Use superscript a, b, c… as identifiers
• Supply Line Art 900 dpi, Combination (Line Art + Halftone) 900 dpi, Halftone 300 dpi
• Graphics downloaded from Web pages are NOT acceptable
• Submit multi-panel figures, ie with parts labeled a,b,c,d, as one file
Any supplementary data should be kept to 6 typeset pages or 2,400 words.
Letter to the Editor
Manuscripts submitted as a Letter to the Editor:
• Should relate to a paper previously published in a Ediscience Medical Press journal, or address an issue of wider concern within the scope of the journal;
• Have a word count of no more than 3,600 words;
• May contain figures and tables (see specifications for these above);
• Have references formatted in the Ediscience Press Journal.
Submission of Manuscript
• All manuscripts should be submitted via our website.
• By doing so you agree to the terms and conditions of submission
• Keep a backup and hard copies of the material submitted
Type of articles
• Original paper
• Clinical studies
• Meta analysis
• Letter to Editor
• Policy Studies
• Case report
Each article must include an abstract divided into:
Absract is not required for Case Report and Letter to Editor
Authorship and Confict of Interest
After confirming the acceptance of the manuscript , the author will have to sign and send back the form for Authorship and Conflict of Interest.
• You will receive the typeset page proofs for approval
• Check amendments made by the editor have not rendered the material inaccurate
• Check you have answered all the editor’s queries • Ensure your corrections are minimal and absolutely necessary
• Mark the adjustments clearly in the text and margins, and keep a copy of what you send to the editor
• Notify the editorial office of all corrections within 72 hours of your receipt of the material
• Ensure all authors sign and return the Author Approval and final page of Publication Agreement
• We also support the international standards for editors and authors that were developed at the 2nd World Conference on Research Integrity in Singapore in 2010.
Please note that authors are responsible for the accuracy and completeness of their references.
Text citations: Cite references sequentially in text, tables, and legends by superscript Arabic numerals with no parentheses, eg, 1 or 3,4 or 10–15. Numbers should be placed after punctuation marks, eg, .3,4 Do not use Microsoft Word’s footnote/endnotes function to build the reference list as this can introduce errors during the typesetting process.
Reference list: List items numerically in the order they are cited in the text, eg, 4. Kapur NK, Musunuru K. Clinical efficiency and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4(2):341–353. Some commonly used sample references follow.
Standard journal article:
Kapur NK, Musunuru K. Clinical efficiency and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2008;4(2):341–353.
List all authors if six or less, otherwise list first three only, followed by "et al.":Brandén E, Gnarpe J, Hillerdal G, et al. Detection of Chlamydia pneumoniae on cytospin preparations from bronchiolar lavage in COPD patients and in lung tissue from advanced emphysema. Int J Chron Obstruct Pulmon Dis. 2007;2(4):643–650.
Group as author:
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679–686.
Both personal authors and an organization as author:
Munakata M, Honma H, Akasi M; for J-STOPMetS Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. Vasc Health Risk Manag. 2007;4(2):415–420.
Volume with no issue but a supplement:
Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 (Suppl 2):S93–S99.
Issue with supplement:
Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6–S12.
Volume with part:
Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. IntJ Psychoanal. 2002;83(Pt 2):491–495.
Issue with part:
Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923–928.
Issue with no volume:
Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230–238.
No volume or issue:
Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1–6.
Type of article indicated as needed:
Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.
Article published electronically ahead of the print:
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828–3831. Epub 2002 Jul 5.
Virchow R. Aetiologie der neoplastischen Geschwulst/Pathogenie der neoplastischen Geschwulste [Etiology and pathology of cancerous tumors]. Die Krankhaften Geschwulste. Berlin: Verlag von August Hirschwald; 1865:57–101. German.
Books and other monographs
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical Microbiology. 4th ed. St Louis: Mosby; 2002.
Editor(s), compiler(s) as author:
Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, eds. Operative Obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
Author(s) and editor(s):
Breedlove GK, Schorfheide AM. Adolescent Pregnancy. 2nd ed. Wieczorek RR, ed. White Plains (NY): March of Dimes Education Services; 2001.
Chapter in a book:
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 2002:93–113.
Conference proceedings (published):
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13–15; Leeds, UK. New York: Springer; 2002.
Conference proceedings (unpublished):
Eisenberg J. Market forces and physician workforce reform: why they may not work. Poster presented at: Annual Meeting of the Association of American Medical Colleges; October 28; 1995; Washington, DC.
Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1.
Other published material
Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).
Ampyra® (dalfampridine) extended release tablets [prescribing information]. New York: Acorda Therapeutics, Inc; 2010. Package insert: Coumadin® (warfarin sodium) [package insert]. Princeton, NJ: Bristol-Myers Squibb; 2010.
Etsey AN. Effects of Regular Ingestion of Natural Cocoa on Testicular Histology in Streptozotocin-Induced Diabetic Rats [dissertation]. Accra: University of Ghana; 2009.
Pfizer. A study in patients with non-small cell lung cancer testing if erlotinib plus SU011248 (sunitinib) is better than erlotinib alone (SUN1058). Available from: http://www.clinicaltrials.gov/ct2/show/NCT00265317. NLM identifier: NCT00265317. Accessed August 1, 2011.
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. In press 2002.
Journal article on the Internet:
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. http://www.nursingworld.org/AJN/2002/june/Wawatch.htm. Accessed April 3, 2003.
Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/. Accessed August 29, 2003. *Iverson C, Christiansen S, Flanagin A, et al. AMA Manual of Style: A Guide for Authors and Editors. 10th ed. New York, NY: Oxford University Press; 2007.